Product image

Leflox Tablets

Leflox Tablets – Broad-Spectrum Fluoroquinolone Therapy

Leflox Tablets are a potent broad-spectrum antibiotic containing Levofloxacin, designed to treat a wide variety of bacterial infections in adults. It is highly effective for respiratory conditions, including acute bacterial sinusitis, community-acquired pneumonia, and nosocomial pneumonia. It also provides reliable treatment for acute bacterial exacerbations of chronic bronchitis, helping patients restore respiratory health.

Beyond the lungs, Leflox manages chronic bacterial prostatitis and both complicated and uncomplicated urinary tract infections. It is also indicated for the treatment of various skin and skin structure infections, ranging from abscesses and cellulitis to more complicated cases. In specialized clinical care, it is used for the management of inhalational anthrax post-exposure. Leflox works by inhibiting essential bacterial enzymes, effectively stopping the replication of pathogens. The availability of multiple strengths (250mg, 500mg, and 750mg) allows for tailored dosing based on the severity and site of the infection.

  • Treats pneumonia, sinusitis, and bronchitis.
  • Effective for urinary, prostate, and skin infections.
  • Indicated for post-exposure anthrax management.
  • Available as: Tablets 250MG, 500MG, and 750MG.

You may also like

Take it to your cart

Ezole Capsules
Ezole Capsules

Ezole Capsules – Targeted Suppression of Stomach Acid

Ezole Capsules contain Esomeprazole, a potent proton pump inhibitor de...

Risek Capsules
Risek Capsules

Risek Capsules – Comprehensive Acid-Related Disease Management

Risek is a established gastrointestinal treatment used for a...

EN-URA Tablets
EN-URA Tablets

EN-URA Tablets – Targeted Relief for Overactive Bladder

EN-URA is a specialized therapeutic option designed to manage bother...

Saltra Inhaler
Saltra Inhaler

Saltra Inhaler – Comprehensive Respiratory Maintenance Therapy

Saltra Inhaler is a specialized respiratory medication used f...

Image NewsLetter
Icon primary
Newsletter

Subscribe our newsletter

By clicking the button, you are agreeing with our Term & Conditions

Your experience on this site will be improved by allowing cookies Cookie Policy